Viewing Study NCT04406857


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-02-20 @ 4:46 PM
Study NCT ID: NCT04406857
Status: TERMINATED
Last Update Posted: 2025-02-26
First Post: 2020-05-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Rectal Carcinoma View
None Rectal Adenocarcinoma View
None Stage II Rectal Cancer AJCC v8 View
None Stage III Rectal Cancer AJCC v8 View
Keywords: